Noven Gains Phase III Vasomotor Symptoms Candidate With JDS Acquisition

Miami firm predicts four potential new product launches in four years based on specialty pharma JDS’ pipeline.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet